Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review, Clin Infect Dis, vol.37, issue.3, pp.265-280, 2003. ,
Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma, Eur Respir J, vol.37, pp.865-872, 2011. ,
The clinical spectrum of pulmonary aspergillosis, Chest, vol.121, pp.1988-1999, 2002. ,
Significance of Aspergillus fumigatus isolation from respiratory specimens of nongranulocytopenic patients, Eur J Clin Microbiol Infect Dis, vol.22, pp.457-462, 2003. ,
Chronic necrotizing pulmonary aspergillosis: approach to management, Chest, vol.112, pp.541-548, 1997. ,
Itraconazole therapy in aspergillosis: study in 49 patients, J Am Acad Dermatol, vol.23, pp.607-614, 1990. ,
Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis, Clin Infect Dis, vol.34, pp.563-571, 2002. ,
Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group (2002) Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis, N Engl J Med, vol.347, pp.408-415 ,
Voriconazole treatment for lesscommon, emerging, or refractory fungal infections, Clin Infect Dis, vol.36, pp.1122-1131, 2003. ,
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole, Eur J Clin Microbiol Infect Dis, vol.31, pp.1173-1179, 2011. ,
Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, Antimicrob Agents Chemother, vol.46, pp.1032-1037, 2000. ,
Voriconazole: therapeutic review of a new azole antifungal, Expert Rev Anti Infect Ther, vol.2, pp.485-497, 2004. ,
A comparative study of fungicidal activities of voriconazole and amphotericin B against hyphae of Aspergillus fumigatus, J Antimicrob Chemother, vol.55, pp.914-920, 2005. ,
Intrapulmonary penetration of voriconazole in patients receiving an oral prophylactic regimen, Antimicrob Agents Chemother, vol.50, pp.1878-1880, 2006. ,
Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis, Am J Med, vol.119, pp.527-544, 2006. ,
The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis, J Infect, vol.52, pp.133-137, 2006. ,
Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients, Chest, vol.131, pp.1435-1441, 2007. ,
, European Committee on Antimicrobial Susceptibility Testing (EUCAST) (2012) Amphotericin B and Aspergillus spp.: rationale for the EUCAST clinical breakpoints, 2012.
Azole-resistance in Aspergillus: proposed nomenclature and breakpoints, Drug Resist Updat, vol.12, pp.141-147, 2009. ,
, Vfend: summary of product characteristics (revision 17), European Medicines Agency, vol.9, 2009.
Microsatellite markers for typing Aspergillus fumigatus isolates, J Clin Microbiol, vol.36, pp.2413-2418, 1998. ,
URL : https://hal.archives-ouvertes.fr/hal-02685504
In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies, Int J Antimicrob Agents, vol.39, pp.440-443, 2012. ,
Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America, Infectious Diseases Society of America, vol.46, pp.327-360, 2008. ,
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987), Mycoses, vol.31, pp.476-485, 1988. ,
Efficacy and safety of posaconazole for chronic pulmonary aspergillosis, Clin Infect Dis, vol.51, pp.1383-1391, 2010. ,
Japan Chronic Pulmonary Aspergillosis Study Group (JCPASG) et al (2010) Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan, J Infect, vol.61, pp.410-418 ,
Clinical efficacy of micafungin for chronic pulmonary aspergillosis, Med Mycol, vol.45, pp.273-278, 2007. ,
A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan, Scand J Infect Dis, vol.36, pp.372-379, 2004. ,
Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes, Clin Infect Dis, vol.46, pp.201-211, 2008. ,